FDA OKs Abbott’s next-gen MitraClip device

The FDA approves Abbott’s (ABT -0.2%) fourth-generation MitraClip heart valve repair device for the treatment of mitral regurgitation (MR).

The company says the new product, called MitraClip G4, offers an expanded lineup of clip sizes, an alternative leaflet grasping feature and an updated catheter integrated with a pressure monitor that continuously monitors and confirms MR reduction during the procedure, enabling the physician to reposition the device, if necessary, in order to achieve the best performance.

https://seekingalpha.com/news/3477800-fda-oks-abbotts-next-gen-mitraclip-device